Archives
Glyceryl Trinitrate (Anginine) Use in a Cardiovascular Emergency
Pauline Greenland
Lecturer, School of Nursing Sciences, James Cook University, Townsville QLD
Abstract
Glyceryl trinitrate (GTN) is a frequently used drug for patients with cardiovascular problems. In Australia, nurses may give GTN without direction from a medical officer if the health care facility has a treatment algorithm relevant to a patient complaint of chest pain. Adverse reactions and interactions may be serious or life threatening, and some nurses may be unaware of precautions needed to be taken in order to administer GTN safely to ensure best patient outcomes.
Recent nursing, medical and pharmacological literature has been reviewed and is presented in this article for the benefit of nurses who may need to administer GTN in the course of their duties. The actions and interactions of GTN are explored as a guide for nurses to keep in mind when administering GTN to the patient in a cardiovascular emergency.
Keywords
Glyceryl Trinitrate, nurses, cardiovascular, emergency, medication administration, chest pain
References
Bryant B, Knights K and Salerno E (2003) Pharmacology for health professionals, Mosby, Sydney.
Chew KK, Stuckey BGA and Thompson PL (2000) Erectile dysfunction, sildenafil and cardiovascular risk, MJA 172: 279-283.
Dollery C (ed) (1999) Therapeutic Drugs 2nd edn, Churchill Livingstone, Edinburgh.
Fatovich DM and Brown AFT (2004) Pain relief in emergency medicine. In Cameron P, Jelinek G, Kelly A, Murray L, Brown AFT and Heyworth J (eds) Textbook of Adult Emergency Medicine 2nd edn, pp.626-634, Churchill Livingstone: Edinburgh.
Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TDJ, Gardin JM, O'Rourke RA, Pasternak RC and Williams SV (2002) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina). Available at www.acc.org/clinical/guidelines/stable/stable.pdf [accessed May 9 2005].
Haugh KH and Keeling A (2003) Coronary artery disease and dysrhythmias. In Phipps WJ, Monahan FD, Sands JK, Marek JF and Neighbors M (eds) Medical-Surgical Nursing Health and Illness Perspectives 7th edn, pp.645-706, Mosby: St. Louis.
Jackson G, Gillies H and Osterloh I (2005) Past, present and future: a 7-year update of Viagra (sildenafil citrate), International Journal of Clinical Practice 59(6): 680-691.
Katzung BG and Chatterjee K (2004) Vasodilators and the treatment of Angina Pectoris. In Katzung BG (ed) Basic and clinical pharmacology 9th edn, pp.184-200, Lange Medical Books/McGraw-Hill: New York.
Kerins DM, Robertson RM and Robertson D (2001) Drugs used for the treatment of myocardial ischemia. In Hardman JG, Limbird LE and Goodman Gilman A (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics 10th edn, pp.843-868), McGraw Hill: New York.
Lowe D, Donnelly R and Hughes J (2001) Cardiology. In Hughes J, Donnelly R and James-Chatgilaou G (eds) Clinical Pharmacy: a practical approach 2nd edn, pp.295-340, Macmillian Publishers Australia: South Yarra, Australia.
McCance K and Huether SE (2002) Pathophysiology: the biologic basis for disease in adults and children 4th edn, Mosby: St Louis.
Mosby Publishing (1998) Expert 10-minute Physical Examinations, Mosby: St Louis.
Opie LH and White H D (2001) Nitrates. In Opie LH and Gersh BJ (eds) Drugs for the Heart 5th edn, pp.33-52, WB Saunders Company: Philadelphia.
Osinski MT, Rauch BH and Schrör K (2001) Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A, Molecular Pharmacology 59(5): 1044-1050.
Reiss BS and Evans ME (2002) Pharmacological Aspects of Nursing Care, Delmar/Thompson Learning: Albany.
Scott D (2003) Coronary heart disease. In Walker R and Edwards C (eds) Clinical Pharmacy and Therapeutics 3rd edn, pp.279-298, Churchill Livingstone: Edinburgh.
Schwemmer M, Bassenge E, Stoeter M, Hartmann B, Hess U and Fink B (2001) Potentiation of sildenafil-induced hypotension is minimal with nitrates generating a radical intermediate, Journal of Cardiovascular Pharmacology 38: 149-155.
eContent Home